IlluminOss Medical, Inc. is a privately held, commercial-stage medical device company offering a unique, minimally invasive technology for the repair and stabilization of fractures in poor-quality, osteoporotic and pathologically compromised bone.
The IlluminOss system utilizes a light-curable liquid monomer which is infused and contained within a conformable balloon sized to the patient’s anatomy. Illuminated with visible blue light, the liquid monomer is converted into a strong, hardened and patient-conforming intramedullary implant.
The IlluminOss implant provides rapid strength and stability to the compromised bone and can be used standalone or with supplemental hardware fixation devices. Fixation screws can be placed anywhere along the IlluminOss implant, providing 3-5x increased holding power compared to normal bone.
The speed, simplicity and minimally invasive procedure permits the majority of IlluminOss patients to return to their daily living activities far sooner and with substantially reduced use of post-operative pain medications. The IlluminOss system is both FDA-cleared and CE marked and has been used in thousands of surgeries in a wide variety of anatomical sites across both general trauma and metastatic indications.
IlluminOss is headquartered in East Providence, RI. For additional information, including complete list of indications, contraindications, warnings, precautions and risks, visit illuminoss.com